Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

13.9%

11 terminated/withdrawn out of 79 trials

Success Rate

81.4%

-5.1% vs industry average

Late-Stage Pipeline

5%

4 trials in Phase 3/4

Results Transparency

13%

6 of 48 completed trials have results

Key Signals

10 recruiting6 with results10 terminated

Enrollment Performance

Analytics

Phase 1
63(79.7%)
Phase 2
11(13.9%)
Phase 3
3(3.8%)
N/A
1(1.3%)
Phase 4
1(1.3%)
79Total
Phase 1(63)
Phase 2(11)
Phase 3(3)
N/A(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (79)

Showing 20 of 79 trials
NCT05951049Phase 2Active Not Recruiting

A Study of AT-02 in Subjects With Systemic Amyloidosis.

Role: collaborator

NCT07219771Phase 3Recruiting

A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients

Role: collaborator

NCT05876312Phase 1Recruiting

Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Role: collaborator

NCT07235293Phase 2Recruiting

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

Role: collaborator

NCT07401121Phase 1Recruiting

Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis

Role: collaborator

NCT05491421Phase 1Completed

A Study of ZT002 in Healthy Participants

Role: collaborator

NCT06717100Phase 1Completed

Study to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and Nintedanib

Role: collaborator

NCT06429930Phase 1Recruiting

Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults

Role: collaborator

NCT05957081Phase 1Recruiting

Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309

Role: collaborator

NCT05288543Phase 1Terminated

A Study of Orally Administered IPG7236 in Healthy Adult Participants

Role: collaborator

NCT06279871Phase 3Completed

Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults

Role: collaborator

NCT06961565Phase 1Recruiting

PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas

Role: collaborator

NCT06125691Phase 1Completed

Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults

Role: collaborator

NCT04510090Phase 1Completed

Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus

Role: collaborator

NCT05882695Phase 1Completed

Study of SPG302 in Healthy Volunteers and ALS Participants

Role: collaborator

NCT04845321Phase 1Terminated

VNRX-9945 Safety and Pharmacokinetics in Healthy Adult Volunteers

Role: collaborator

NCT04565756Phase 1Completed

A Study to Evaluate the Safety and Tolerability of EXN407

Role: collaborator

NCT04576689Phase 2Completed

Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy

Role: collaborator

NCT05188469Phase 1Completed

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers

Role: collaborator

NCT06557499Not ApplicableRecruiting

A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples.

Role: collaborator